cipla: Cipla unit recalls one lot of medication in US due to seal integrity issue
Drug major Ciplas subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues. InvaGen Pharmaceuticals Inc, USA, is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP (500 mg), at the consumer level due to seal integrity issues, allowing for powder leakage from the pouch, the Mumbai-based drug maker said in a regulatory filing.
United States New Delhi Invagen Pharmaceuticals Inc Invagen Pharmaceuticals Gen Pharmaceuticals Inc Oral Solution
Source: indiatimes.com